STEMREGEN® Clinical Research & Peer-Reviewed Science
Explore published human clinical trials, biological mechanism of action monographs, and safety dossiers.
The Science & Vision of Christian Drapeau, MSc
Neurophysiologist, Founder, and Pioneer of the Science of Endogenous Stem Cell Mobilization.

Christian Drapeau, MSc in the Analytical & Formulation Laboratory
Christian Drapeau, MSc
Neurophysiologist · McGill University Graduate · 9 Patents in Stem Cell Science
Christian Drapeau is a neurophysiologist and the global pioneer in adult stem cell science. Trained in neurophysiology at the Montreal Neurological Institute, McGill University, Drapeau was the first researcher to propose — in a landmark peer-reviewed 2002 publication in Medical Hypotheses — that adult bone marrow stem cells constitute the natural repair system of the human body.
Over the past twenty-three years, he has led the identification and isolation of natural botanical extracts that support endogenous stem cell mobilization, earning nine international patents and authoring 28+ scientific publications — spanning peer-reviewed clinical studies, book chapters, and monographs — verified on ResearchGate and Google Scholar.

Cracking the Stem Cell Code
Demystifying the Most Dramatic Scientific Breakthrough of Our Times (256 pp). In this acclaimed book, Drapeau synthesizes two decades of clinical and biological research explaining how adult stem cells serve as the body's repair engine and how plant-based mobilizers support systemic tissue renewal.
Mobilization of Human CD34+CD133+ and CD34+CD133- Stem Cells In Vivo by Consumption of an Extract from Aphanizomenon flos-aquae — Related to Modulation of CXCR4 Expression by an L-Selectin Ligand?
Jensen G.S., Hart A.N., Zaske L.A.M., Drapeau C., Gupta N., Schaeffer D.J., Cruickshank J.A. — Cardiovascular Revascularization Medicine (8(3): 189-202)
Institution: Holger NIS Inc. (Calgary, Canada), Natural Immune System Inc. (Klamath Falls, OR), Merle West Medical Center & University of Illinois at Urbana-Champaign
Evaluated whether an aqueous extract from the cyanophyta Aphanizomenon flos-aquae (AFA-W) contains a novel ligand for human CD62L (L-selectin) that modulates CXCR4 chemokine receptor expression on CD34+ bone marrow cells in vitro and triggers transient mobilization of CD34+CD133+ and CD34+CD133- stem cells into peripheral blood in humans.
Rapid and Selective Mobilization of Specific Stem Cell Types After Consumption of a Polyphenol-Rich Extract from Sea Buckthorn Berries (Hippophae) in Healthy Human Subjects
Drapeau C., Benson K.F., Jensen G.S. — Clinical Interventions in Aging (14: 253-263)
Institution: NIS Labs (Klamath Falls, OR, USA) & Kalyagen Inc. (Addison, TX, USA)
Randomized, double-blind, placebo-controlled crossover clinical trial (ClinicalTrials.gov NCT03388073; Sky Lakes Medical Center IRB FWA 2603) evaluating whether oral consumption of a single 500 mg dose of a proanthocyanidin-rich extract of Tibetan sea buckthorn berries (Hippophae rhamnoides, SBB-PE) triggers rapid and selective mobilization of specific stem cell phenotypes in healthy human subjects (n = 12).
Aloe macroclada from Madagascar Triggers Transient Bone Marrow Stem Cell Mobilization
Drapeau C., Benson K.F., James J., Jensen G.S. — Journal of Stem Cell Research & Therapy (5(6): 287)
Institution: Stemtech International (San Clemente, CA), Natural Immune System Labs (Klamath Falls, OR) & Mioty Voajanahary (Madagascar)
Randomized, double-blind, placebo-controlled crossover pilot study evaluating the traditional Malagasy preparation of Aloe macroclada (Vahona)—historically documented in the 1901 Dandouau Catalog as a factor of rejuvenation and longevity—for its capacity to trigger acute mobilization of CD45dim CD34+ and CD34+ CD133+ bone marrow stem cells in healthy human subjects.
The Effect of Endogenous Stem Cell Mobilization on Congestive Heart Failure
Drapeau C., Komaran G., Pedrero F., Garber M. — Stem Cell & Regenerative Medicine (9(1): 1-8)
Institution: STEMREGEN Research (Whitefish, MT, USA) & Madrid Clinical Cardiology Group (Madrid, Spain)
Prospective 6-month clinical study evaluating whether daily plant-based Endogenous Stem Cell Mobilization (ESCM) using STEMREGEN® RELEASE improves cardiac function, neurohormonal ventricular stress biomarkers, and angina-related quality of life in patients (n = 10) with chronic stable congestive heart failure (NYHA Class II–III, baseline LVEF < 45%).
The Therapeutic Potential of Stimulating Endogenous Stem Cell Mobilization
Drapeau C., Eufemio G., Mazzoni P., Roth G.D., Strandberg S. — Tissue Regeneration — From Basic Biology to Clinical Application (InTechOpen) (Chapter 8, pp. 167-202)
Institution: Stemtech International (San Clemente, CA), Cardinal Santos Medical Center (Manila, Philippines), Neurology and Psychiatry Center (Ostfildern, Germany) & Stem Cell Center (Spokane, WA)
Comprehensive 36-page peer-reviewed book chapter examining the physiology of bone marrow stem cell egress (G-CSF, SDF-1/CXCR4, MMP-9, and L-selectin adhesion dynamics), comparing pharmacological mobilizers (G-CSF, Mozobil®/Plerixafor) with natural botanical stem cell mobilizers (Aphanizomenon flos-aquae L-selectin ligand, Fucus vesiculosus and Undaria pinnatifida fucoidans), and reviewing multi-organ tissue regeneration across cardiac, neurological, hepatic, pancreatic, renal, cutaneous, and orthopedic models.
Determination of the Number of Stem Cells Released by One Serving (2 Capsules) of STEMREGEN® RELEASE
Christian Drapeau, MSc — STEMREGEN Clinical White Paper & Mechanistic Synthesis (Second Edition (November 2024 · 12 pages))
Institution: STEMREGEN Research & Development
Evaluates the total endogenous stem cell mobilization triggered by one serving (2 capsules) of STEMREGEN® RELEASE by synthesizing double-blind, placebo-controlled human flow-cytometry trials and mechanistic receptor studies across its active botanical extracts: Aphanizomenon flos-aquae (AFA), Tibetan Hippophae rhamnoides berry extract, Malagasy Aloe macroclada (Vahona), Fucus vesiculosus fucoidan, Panax notoginseng saponins, and bovine colostrum.
The Effects of Stemregen® Host Modulation Therapy on Experimentally Induced Apical Periodontitis in Rats
Gönüllü F., Ocak M.S., Dündar S., Özercan İ.H. — Journal of Applied Oral Science (33: e20240446)
Institution: Fırat University Faculty of Dentistry & Faculty of Medicine (Elazığ, Turkey) & Isparta Oral and Dental Health Center
Controlled in-vivo study investigating the osteogenic, anti-inflammatory, and periapical host-modulation effects of systemic STEMREGEN® administration (300 mg/kg/day for 30 days) on experimentally induced mandibular first-molar apical periodontitis in Sprague-Dawley rats (n = 27).
Mobilization of Bone Marrow Stem Cells with StemEnhance® Improves Muscle Regeneration in Cardiotoxin-Induced Muscle Injury
Drapeau C., Antarr D., Ma H., Yang Z., Tang L., Hoffman R.M., Schaeffer D.J. — Cell Cycle (9(9): 1819-1823)
Institution: Stemtech HealthSciences (San Clemente, CA), AntiCancer Inc. (San Diego, CA), Department of Surgery, University of California San Diego & University of Illinois at Urbana-Champaign
Evaluated whether daily oral administration of StemEnhance® (SE), an Aphanizomenon flos-aquae L-selectin ligand concentrate, enhances the homing and incorporation of green fluorescent protein-expressing (GFP+) bone marrow-derived stem cells into regenerating skeletal muscle following cardiotoxin-induced myonecrosis in lethally irradiated C57BL/6 mice.
Use of Stem Cell Mobilizer SE2® as Part of Conventional Treatment on Ankle Injuries to Expedite Recovery in Professional Soccer Players
Garber M., Mazzoni P., Nazir C., Drapeau C. — Journal of Advancement in Medical and Life Sciences (2(3): 1-4)
Institution: Clínica Quantum (Madrid, Spain), Rayo Majadahonda Medical Staff (Madrid, Spain) & Stemtech R&D
Randomized, pair-matched controlled clinical evaluation of 12 male professional soccer players (Rayo Majadahonda, Spain; ages 18–22) presenting with acute Grade II ankle sprains (partial ligament tearing, swelling, and joint instability without fracture). Evaluated whether adding daily oral stem cell mobilization (SE2® and StemFlo®) to standard sports medicine rehabilitation accelerates soft-tissue repair and return to play.
Cardiovascular Disease: A Global Challenge and the Need for Regenerative Solutions
Christian Drapeau, MSc — STEMREGEN Clinical White Paper Series (First Edition (December 2024 · 24 pages))
Institution: STEMREGEN Research & Development
Examines the limitations of conventional symptom-focused cardiovascular pharmacotherapy and reviews the regenerative role of endogenous bone marrow stem cells and endothelial progenitor cells (EPCs) in cardiomyocyte renewal, myocardial neovascularization, anti-inflammatory cytokine modulation, and attenuation of post-ischemic cardiac fibrosis. Includes 6-month human clinical outcome data in chronic stable heart failure patients supplementing with STEMREGEN® RELEASE.
Understanding the Natural Role of Stem Cells in the Body: A New Understanding of Disease Formation?
Christian Drapeau — Journal of Stem Cell Research & Therapy (3(3): 1000e116)
Institution: Stemtech International, San Clemente, CA, USA
Growing literature demonstrates that endogenous bone marrow stem cells constitute the natural repair and daily renewal system of the human body. Following acute injuries such as myocardial infarction, skin burns, bone fractures, and stroke, affected tissues release Granulocyte-Colony Stimulating Factor (G-CSF) to mobilize bone marrow stem cells into peripheral blood circulation, which then migrate into damaged tissue and differentiate to participate in repair. Beyond acute injury, sex-mismatched transplant chimerism and carbon-14 (C14) retrospective DNA birth-dating studies reveal continuous steady-state cellular turnover across vital organs. Because a healthy 40-year-old adult has replaced major organs multiple times without developing organ failure, degenerative disease is not caused simply by cellular loss, but rather by a decline in endogenous stem cell-based renewal—when the rate of cellular loss exceeds the rate of stem cell-mediated tissue repair.
The Use of In Situ Bone Marrow Stem Cells for the Treatment of Various Degenerative Diseases
Gitte S. Jensen, PhD; Christian Drapeau, MSc — Medical Hypotheses (59(4): 422-428)
Institution: Holger NIS Inc. & Desert Lake Technologies
First comprehensive peer-reviewed scientific paper (PMID: 12208182) to propose the hypothesis that in situ mobilization of adult stem cells from the bone marrow and their migration to various tissues is the body's normal physiological process of regeneration and repair, and that natural compounds augmenting endogenous stem cell mobilization offer a non-invasive therapeutic avenue for degenerative conditions.
Ensuring the Safety of Aphanizomenon flos-aquae (AFA): A Scientific Review of Klamath Lake Harvests
Christian Drapeau, MSc — STEMREGEN Quality & Toxicology Monograph Series (First Edition (October 2024 · 9 pages))
Institution: STEMREGEN Quality Assurance & Regulatory Science
Scientific review addressing the genomic profile, toxicology, and quality assurance standards of wild-harvested Upper Klamath Lake Aphanizomenon flos-aquae (AFA). Synthesizes whole-genome sequencing data (Driscoll et al., 2018), regulatory toxicology benchmarks (Carmichael, Drapeau & Anderson, 2000), and subacute/90-day subchronic animal safety studies (Dirikolu et al., 2010, 2011) confirming the non-toxic profile of clinical-grade Klamath Lake AFA.
The Human Repair System: Endogenous Stem Cell Mobilization as the Body's Innate System of Repair and Renewal
Christian Drapeau, MSc — STEMREGEN Science & Clinical Monograph Series (First Edition (64 pages · 66 Peer-Reviewed References))
Institution: STEMREGEN Research & Development
Comprehensive 64-page scientific monograph by Christian Drapeau, MSc synthesizing 66 peer-reviewed studies on how adult bone marrow stem cells constitute the body's innate system of tissue repair and daily cellular renewal. Details green fluorescent protein (GFP) lineage-tracing discoveries, red-to-yellow bone marrow conversion with aging, the relationship between circulating stem cell levels and chronic degenerative conditions, and clinical evidence for botanical Endogenous Stem Cell Mobilization (ESCM).
Leveraging Stem Cell Activity: The Synergistic Power of PEMF and the STEMREGEN Protocol
Christian Drapeau, MSc — STEMREGEN Clinical Biophysics & Integrative Medicine Monograph Series (First Edition (August 2025 · 23 pages))
Institution: STEMREGEN Research & Development
Investigates the mechanistic and clinical synergy between Pulsed Electromagnetic Field (PEMF) therapy and the three-part STEMREGEN® Protocol (Release, Mobilize, and Signal) across 38 peer-reviewed studies. Demonstrates how pairing endogenous stem cell mobilization, endothelial glycocalyx support, and systemic anti-inflammatory signaling with PEMF-induced transmembrane potential optimization and SDF-1/CXCR4 upregulation amplifies tissue regeneration across bone, cartilage, muscle, and neural tissues.
Stem Cells: Could They Be the Answer to Muscle Soreness, Overuse Injuries and Hypertrophy?
Christian Drapeau, MSc — STEMREGEN Sports Medicine & Orthopedic Monograph Series (First Edition (October 2024 · 24 pages))
Institution: STEMREGEN Research & Development
Explores the cellular mechanisms governing skeletal muscle repair, delayed onset muscle soreness (DOMS), cumulative microtrauma (overuse injuries), and exercise-induced hypertrophy across 39 peer-reviewed studies. Details how bone marrow-derived stem cells (BMDSCs) mobilized via Endogenous Stem Cell Mobilization (ESCM) migrate to exercised or injured muscle fibers to replenish the resident satellite cell pool, donate myonuclei for protein synthesis, and prevent fibrotic scar tissue formation.
Integrate These Clinical Protocols Into Your Practice
Connect with our Medical Science Liaison to schedule a call or apply for in-clinic wholesale dispensing.